H o t _S t o c k for attention.Xact Aid Inc. (XAID)A bio-medical Company
focused on diagnostic testing in the area of sexually transmitted diseases
(STD).Current Price: .65Is XAID an Undiscovered Gem that is Positioned to Go
Higher? Please
Review Exactly the h0t press release.Does it Sound New and Exciting to You?
Watch This One Trade.Sep 28, 2005 -- Xact Aid, Inc. (XAID - News) is pleased to
announce the acquisition of a License granting the Company the world wide right
to
use, under its brand name, a patent-pending F.D.A. 510(K) cleared device to be
utilized in a new diagnostic rapid-test product which will be announced in the
near future.According to the Company's President, Robert Pautsch, "We are very
excited by the granting to us of this license, which will enable Xact Aid to
move forward with the development of a new diagnostic product targeting the
sexually transmitted disease ("STD") marketplace."
About Xact AidXact Aid Inc. is a bio medical firm focusing on life science
solutions for the sexually transmitted disease marketplace.Conclusion:The
Examples Above Show The Awesome, Earning Potential of Little Known
Companies That Explode Onto Investor's Radar Screens; Many of You Are Already
Familiar with This. Is XAID Poised and Positioned to Do that For You? Then You
May Feel the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go XAID.Penny stocks are considered highly speculative
and may be unsuitable for all but very aggressive investors. This Profile is
not in any way affiliated with the featured company. This report is for
entertainment
and advertising purposes only and should not be used as investment advice. If
you wish to stop future mailings, or if you feel you have been wrongfully
placed in our membership, send a blank e mail with No Thanks
in the sub ject to suik@yahoo
|